EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Induction of oral tolerance to diphtheria toxin by feeding mice with formalinized diphtheria nontoxic mutant CRM197



Induction of oral tolerance to diphtheria toxin by feeding mice with formalinized diphtheria nontoxic mutant CRM197



FASEB Journal 12(4): A599, March 17




(PDF emailed within 1 workday: $29.90)

Accession: 031906152

Download citation: RISBibTeXText



Related references

Transgenic mice expressing a fully nontoxic diphtheria toxin mutant, not CRM197 mutant, acquire immune tolerance against diphtheria toxin. Journal of Biochemistry 142(1): 105-112, 2007

Differences in the immunogenicity of native and formalinized cross reacting material (CRM197) of diphtheria toxin in mice and guinea pigs and their implications on the development and control of diphtheria vaccine based on CRMs. Vaccine 15(12-13): 1341-1343, 1997

Cancer immunotherapy with CRM197, a nontoxic mutant of diphtheria toxin. International Journal of Molecular Medicine 8(Supplement 1): S26, 2001

Comparison of the diphtheria mutant toxin, CRM197, with a Haemophilus influenzae type-b polysaccharide-CRM197 conjugate by optical spectroscopy. European Journal Of Biochemistry. 246(2): 320-327, 1997

CRM197 (nontoxic diphtheria toxin): effects on advanced cancer patients. Cancer Immunology, ImmunoTherapy 53(11): 1041-1048, 2004

Diphtheria toxin and related proteins part 3 reconstitution of hybrid diphtheria toxin from nontoxic mutant proteins. Journal of Biological Chemistry 248(11): 3851-3854, 1973

Transgenic mice expressing a fully nontoxic diphtheria toxin mutant,. 2007

Diphtheria toxin and related proteins. 3. Reconstitution of hybrid "diphtheria toxin" from nontoxic mutant proteins. Journal of Biological Chemistry 248(11): 3851-3854, 1973

Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM(197), a mutant diphtheria toxin. Infection and Immunity 69(2): 869-874, 2001

Mucosal vaccination against diphtheria using starch microparticles as adjuvant for cross-reacting material (CRM197) of diphtheria toxin. Vaccine 23(21): 2775-2783, 2005

Inhibition of adrenocortical carcinoma by diphtheria toxin mutant CRM197. ChemoTherapy 55(6): 425-432, 2010

Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197. Proceedings of the National Academy of Sciences of the United States of America 109(14): 5229-5234, 2012

Chitosan as a mucosal delivery system for CRM197, a mutant of diphtheria toxin. Immunology Letters 69(1): 59, June 15, 1999

Expression, purification and characterization of diphtheria toxin mutant CRM197 in Eschrichia coli. Sheng Wu Gong Cheng Xue Bao 34(4): 561-568, 2019

A mucosal vaccine against diphtheria: Formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery. Vaccine 19(9-10): 1188-1198, 2000